Who invested in Vivaldi Biosciences?
Vivaldi Biosciences's investors include Bay City Capital.

United States · Venture startup
2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Vivaldi Biosciences and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$4.0Mraised across 2 rounds since 2007, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Jul 2010
Vivaldi Biosciences filed one raise, $2.0M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Vivaldi Biosciences's own website and the SEC filings it signed: 8 on the team.
On the board, as filediGeorg NebgenPeter JohannVic SchmittWilliam Gerber
Vivaldi Biosciences's investors include Bay City Capital.
Vivaldi Biosciences has raised $4.0M across 2 rounds since 2007.
Vivaldi Biosciences's most recent round was a Venture of $2.0M in Jul 2010.
Vivaldi Biosciences's largest round on record is $2.0M (Series A), in May 2007.
Vivaldi Biosciences's first round on record, in May 2007, was backed by Bay City Capital.
Vivaldi Biosciences's latest named round is a Venture, in Jul 2010.
Vivaldi Biosciences is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.